522 related articles for article (PubMed ID: 11346064)
1. Linezolid for the treatment of resistant gram-positive cocci.
Bain KT; Wittbrodt ET
Ann Pharmacother; 2001 May; 35(5):566-75. PubMed ID: 11346064
[TBL] [Abstract][Full Text] [Related]
2. Treatment options for vancomycin-resistant enterococcal infections.
Linden PK
Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
[TBL] [Abstract][Full Text] [Related]
3. Use of linezolid in children: an overview of recent advances.
Velissariou IM
Expert Rev Anti Infect Ther; 2006 Dec; 4(6):947-52. PubMed ID: 17181410
[TBL] [Abstract][Full Text] [Related]
4. Linezolid: a review of its use in the management of serious gram-positive infections.
Perry CM; Jarvis B
Drugs; 2001; 61(4):525-51. PubMed ID: 11324682
[TBL] [Abstract][Full Text] [Related]
5. Linezolid: an oxazolidinone antimicrobial agent.
Fung HB; Kirschenbaum HL; Ojofeitimi BO
Clin Ther; 2001 Mar; 23(3):356-91. PubMed ID: 11318073
[TBL] [Abstract][Full Text] [Related]
6. Tedizolid: a new oxazolidinone antimicrobial.
Kisgen JJ; Mansour H; Unger NR; Childs LM
Am J Health Syst Pharm; 2014 Apr; 71(8):621-33. PubMed ID: 24688035
[TBL] [Abstract][Full Text] [Related]
7. Clinical and microbiologic efficacy and safety profile of linezolid, a new oxazolidinone antibiotic.
Corti G; Cinelli R; Paradisi F
Int J Antimicrob Agents; 2000 Dec; 16(4):527-30. PubMed ID: 11118873
[TBL] [Abstract][Full Text] [Related]
8. Linezolid--a review of the first oxazolidinone.
Norrby R
Expert Opin Pharmacother; 2001 Feb; 2(2):293-302. PubMed ID: 11336587
[TBL] [Abstract][Full Text] [Related]
9. Linezolid: pharmacokinetic characteristics and clinical studies.
Bouza E; Muñoz P
Clin Microbiol Infect; 2001; 7 Suppl 4():75-82. PubMed ID: 11688537
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of linezolid versus comparator therapies in Gram-positive infections.
Wilcox MH
J Antimicrob Chemother; 2003 May; 51 Suppl 2():ii27-35. PubMed ID: 12730140
[TBL] [Abstract][Full Text] [Related]
11. Linezolid: in infants and children with severe Gram-positive infections.
Lyseng-Williamson KA; Goa KL
Paediatr Drugs; 2003; 5(6):419-29; discussion 430-1. PubMed ID: 12765493
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic perspectives of linezolid in the management of infections due to multiresistant Gram-positive pathogens].
Manfredi R
Recenti Prog Med; 2007 Mar; 98(3):143-54. PubMed ID: 17484159
[TBL] [Abstract][Full Text] [Related]
13. Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.
Zhanel GG; Love R; Adam H; Golden A; Zelenitsky S; Schweizer F; Gorityala B; Lagacé-Wiens PR; Rubinstein E; Walkty A; Gin AS; Gilmour M; Hoban DJ; Lynch JP; Karlowsky JA
Drugs; 2015 Feb; 75(3):253-70. PubMed ID: 25673021
[TBL] [Abstract][Full Text] [Related]
14. Linezolid in children: recent patents and advances.
Velissariou IM
Recent Pat Antiinfect Drug Discov; 2007 Jan; 2(1):73-7. PubMed ID: 18221164
[TBL] [Abstract][Full Text] [Related]
15. [Role of linezolid in antimicrobial therapy].
Carmona PM; Romá E; Monte E; García J; Gobernado M
Enferm Infecc Microbiol Clin; 2003 Jan; 21(1):30-41. PubMed ID: 12550042
[TBL] [Abstract][Full Text] [Related]
16. Multicenter assessment of the linezolid spectrum and activity using the disk diffusion and Etest methods: report of the Zyvox(R) antimicrobial potency study in Latin America (LA-ZAPS).
Ballow CH; Biedenbach DJ; Rossi F; Jones RN;
Braz J Infect Dis; 2002 Jun; 6(3):100-9. PubMed ID: 12144745
[TBL] [Abstract][Full Text] [Related]
17. The oxazolidinones as a new family of antimicrobial agent.
Marchese A; Schito GC
Clin Microbiol Infect; 2001; 7 Suppl 4():66-74. PubMed ID: 11688536
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of linezolid & quinupristin/dalfopristin against Gram-positive cocci.
Tünger A; Aydemir S; Uluer S; Cilli F
Indian J Med Res; 2004 Dec; 120(6):546-52. PubMed ID: 15654141
[TBL] [Abstract][Full Text] [Related]
19. The pharmacologic and bacteriologic properties of oxazolidinones, a new class of synthetic antimicrobials.
Dresser LD; Rybak MJ
Pharmacotherapy; 1998; 18(3):456-62. PubMed ID: 9620097
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of linezolid in the treatment of skin and soft tissue infections.
Hau T
Eur J Clin Microbiol Infect Dis; 2002 Jul; 21(7):491-8. PubMed ID: 12172739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
